| Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains D Sauter, M Schindler, A Specht, WN Landford, J Münch, KA Kim, ... Cell host & microbe 6 (5), 409-421, 2009 | 512 | 2009 |
| Self-reactive antibodies (natural autoantibodies) in healthy individuals S Lacroix-Desmazes, SV Kaveri, L Mouthon, A Ayouba, E Malanchère, ... Journal of immunological methods 216 (1-2), 117-137, 1998 | 487 | 1998 |
| SIVcpz in wild chimpanzees ML Santiago, CM Rodenburg, S Kamenya, F Bibollet-Ruche, F Gao, ... Science 295 (5554), 465-465, 2002 | 308 | 2002 |
| Origin of the HIV-1 group O epidemic in western lowland gorillas M D’arc, A Ayouba, A Esteban, GH Learn, V Boué, F Liegeois, L Etienne, ... Proceedings of the National Academy of Sciences 112 (11), E1343-E1352, 2015 | 295 | 2015 |
| African origin of the malaria parasite Plasmodium vivax W Liu, Y Li, KS Shaw, GH Learn, LJ Plenderleith, JA Malenke, ... Nature communications 5 (1), 3346, 2014 | 255 | 2014 |
| env Sequences of Simian Immunodeficiency Viruses from Chimpanzees in Cameroon Are Strongly Related to Those of Human Immunodeficiency Virus Group N … S Corbet, MC Müller-Trutwin, P Versmisse, S Delarue, A Ayouba, ... Journal of virology 74 (1), 529-534, 2000 | 235 | 2000 |
| Origin and biology of simian immunodeficiency virus in wild-living western gorillas J Takehisa, MH Kraus, A Ayouba, E Bailes, F Van Heuverswyn, ... Journal of virology 83 (4), 1635-1648, 2009 | 219 | 2009 |
| Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa A Gessain, P Mauclère, M van Beveren, S Plancoulaine, A Ayouba, ... International journal of cancer 81 (2), 189-192, 1999 | 213 | 1999 |
| Genomes of cryptic chimpanzee Plasmodium species reveal key evolutionary events leading to human malaria SA Sundararaman, LJ Plenderleith, W Liu, DE Loy, GH Learn, Y Li, ... Nature communications 7 (1), 11078, 2016 | 165 | 2016 |
| Foci of Endemic Simian Immunodeficiency Virus Infection in Wild-Living Eastern Chimpanzees (Pan troglodytes schweinfurthii) ML Santiago, M Lukasik, S Kamenya, Y Li, F Bibollet-Ruche, E Bailes, ... Journal of virology 77 (13), 7545-7562, 2003 | 153 | 2003 |
| HIV-1 group N among HIV-1-seropositive individuals in Cameroon A Ayouba, S Souquières, B Njinku, PMV Martin, MC Müller-Trutwin, ... Aids 14 (16), 2623-2625, 2000 | 153 | 2000 |
| Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks AK Keita, FR Koundouno, M Faye, A Düx, J Hinzmann, H Diallo, ... Nature 597 (7877), 539-543, 2021 | 148 | 2021 |
| Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions AF Aghokeng, A Ayouba, E Mpoudi-Ngole, S Loul, F Liegeois, ... Infection, Genetics and Evolution 10 (3), 386-396, 2010 | 141 | 2010 |
| Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study JF Etard, MS Sow, S Leroy, A Touré, B Taverne, P Msellati, S Baize, ... The Lancet Infectious Diseases 17 (5), 545-552, 2017 | 130 | 2017 |
| The origin and molecular epidemiology of HIV M Peeters, M Jung, A Ayouba Expert review of anti-infective therapy 11 (9), 885-896, 2013 | 121 | 2013 |
| HIV-1 group O infection in Cameroon, 1986 to 1998. A Ayouba, P Mauclère, PM Martin, P Cunin, J Mfoupouendoun, B Njinku, ... Emerging infectious diseases 7 (3), 466, 2001 | 120 | 2001 |
| Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Côte d’Ivoire A Ayouba, C Akoua-Koffi, S Calvignac-Spencer, A Esteban, S Locatelli, ... Aids 27 (15), 2488-2491, 2013 | 116 | 2013 |
| Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open … A Calmy, TT Sanchez, C Kouanfack, M Mpoudi-Etame, S Leroy, ... The lancet HIV 7 (10), e677-e687, 2020 | 112 | 2020 |
| Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach … AF Aghokeng, M Monleau, S Eymard-Duvernay, A Dagnra, D Kania, ... Clinical infectious diseases 58 (1), 99-109, 2014 | 112 | 2014 |
| Hepatitis C virus infection in Cameroon: A cohort‐effect E Nerrienet, R Pouillot, G Lachenal, R Njouom, J Mfoupouendoun, ... Journal of medical virology 76 (2), 208-214, 2005 | 99 | 2005 |
Eric DelaporteProfessor of Infectious Diseases,IRD,Université de MontpellierVerified email at ird.fr
